QL
MLTX icon

Quarry LP’s MoonLake Immunotherapeutics MLTX Stock Holding History

Quarry LP’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$396K Buy
+21,250
New +$352K 0.07% 193
2025
Q4 		– Sell
-9,001
Closed -$64.5K – 2433
2025
Q3 		$64.5K Buy
9,001
+7,201
+400% +$375K 0.01% 710
2025
Q2 		$85K Sell
1,800
-600
-25% -$24.4K 0.02% 624
2025
Q1 		$93.8K Buy
+2,400
New +$103K 0.02% 544
2024
Q3 		– Sell
-3,000
Closed -$132K – 1901
2024
Q2 		$132K Buy
3,000
+1,900
+173% +$80.5K 0.04% 261
2024
Q1 		$55.3K Buy
1,100
+250
+29% +$13.6K 0.01% 418
2023
Q4 		$51.3K Buy
+850
New +$43.8K 0.01% 324

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quarry LP's MLTX Position: Q1 2026 in Review

Quarry LP opened a new position in MoonLake Immunotherapeutics (MLTX) in Q1 2026: 21,250 shares worth $396K. The stake represents 0.07% of the portfolio and ranks #193 among its holdings. This is a return to the name: Quarry LP previously reported a position in MLTX as recently as Q3 2025.

Quarry LP first reported a position in MLTX in Q4 2023 and has held it in 7 quarters since. 147 funds tracked by Wall St. Rank hold MLTX as of Q1 2026.

  • Quarry LP held 21,250 shares of MoonLake Immunotherapeutics worth $396K as of Q1 2026.
  • MoonLake Immunotherapeutics was a new Quarry LP position in Q1 2026.
  • MoonLake Immunotherapeutics made up 0.07% of Quarry LP's portfolio in Q1 2026, its #193 holding.
  • Quarry LP first reported a position in MoonLake Immunotherapeutics in Q4 2023 and has held it in 7 quarters since.
  • 147 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.